| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 49.0 | 56.3 |
| Profit before tax | -10.2 | -30.7 |
| Net income | -11.4 | -32.4 |
| EPS (diluted, $ a share) | $-0.67 | $-2.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -13.0% |
|---|---|
| Operating margin | -23.8% |
10-Q filed with the SEC, NYSE: AMWL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
American Well Corp: key numbers
- Share price
- $11.34Close, Nov 16
- Sector
- Trade & Services
- Industry
- Services-Business Services, NECSIC 7389
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from American Well Corp
All →American Well Earnings Call: Key Takeaways
Amwell is executing a turnaround focused on platform consolidation and cost discipline, significantly narrowing EBITDA losses despite revenue declines from legacy churn.
American Well Financial Results
American Well Corp (Amwell) reported Q3 2026 total revenue of $49.0 million, exceeding its previous guidance, and a net loss of $11.0 million. The company raised its full-year 2026 revenue outlook to a range of $204-$206 million and reiterated its goal to achieve positive cash flow from operations in the fourth quarter of 2026.
- Term
- Q3 2026
“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three. Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works. We expect to generate positive cash flow from operations in the fourth quarter, and we believe we are well positioned to be the trusted platform where AI-powered care runs.”
Dr. Ido Schoenberg, Chairman and CEO of Amwell
American Well President, International Phyllis Gotlib Sells $86.8K of Stock
Phyllis Gotlib, President, International, sold 6,677 shares of American Well Corp at $13.00 a share, worth $86.8K in total on Oct 1, 2026. Shares held after the trade: 142,504 (-4.5%).
- Value
- $86.8K
- Shares
- 6,677
- Price
- $13.00
- Role
- President, International
- Holding change
- -4.5%
- Trade date
- Oct 1, 2026
American Well CFO Mark Hirschhorn Sells $55.7K of Stock
Mark Hirschhorn, CFO, sold 4,282 shares of American Well Corp at $13.00 a share, worth $55.7K in total on Oct 1, 2026. Shares held after the trade: 223,906 (-1.9%).
- Value
- $55.7K
- Shares
- 4,282
- Price
- $13.00
- Role
- CFO
- Holding change
- -1.9%
- Trade date
- Oct 1, 2026
American Well Chief Product & Tech. Officer Dmitry Zamansky Sells $110K of Stock
Dmitry Zamansky, Chief Product & Tech. Officer, sold 8,442 shares of American Well Corp at $13.00 a share, worth $110K in total on Oct 1, 2026. Shares held after the trade: 224,178 (-3.6%).
- Value
- $110K
- Shares
- 8,442
- Price
- $13.00
- Role
- Chief Product & Tech. Officer
- Holding change
- -3.6%
- Trade date
- Oct 1, 2026